Effect of prehypertensive losartan therapy on AT1R and ATRAP methylation of adipose tissue in the later life of high‑fat‑fed spontaneously hypertensive rats

Wang,Tingjun; Lian,Guili; Cai,Xiaoqi; Lin,Zhihong; Xie,Liangdi

doi:10.3892/mmr.2017.8081

Effect of prehypertensive losartan therapy on AT1R and ATRAP methylation of adipose tissue in the later life of high‑fat‑fed spontaneously hypertensive rats

Authors:
- Tingjun Wang
- Guili Lian
- Xiaoqi Cai
- Zhihong Lin
- Liangdi Xie
View Affiliations

Affiliations: Fujian Hypertension Research Institute, The First Clinical College of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China
Published online on: November 15, 2017 https://doi.org/10.3892/mmr.2017.8081
Pages: 1753-1761
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hypertension is frequently associated with metabolic disorders. The present study was designed to investigate the long‑term effect of prehypertensive losartan therapy on metabolic disorders in high‑fat‑fed spontaneously hypertensive rats (SHRs), and to examine the role of epigenetic regulation of angiotensin II type 1 receptor (AT1R) and AT1 receptor‑associated protein (ATRAP) expression in adipose tissue. A total of 32 4‑week‑old male SHRs were divided into four groups (n=8 rats/group): Standard chow; standard chow + losartan; high‑fat diet; and high‑fat diet + losartan. At 10 weeks of age, treatment with losartan was discontinued. Rats were followed up until 26 weeks of age. Obesity, dyslipidemia, hyperglycemia, abnormal adipokine secretion, larger adipocytes and decreased expression of markers of adipocyte differentiation were present in high‑fat‑fed SHRs, and were attenuated in losartan‑treated rats. The increased expression and promoter hypomethylation of AT1R subtype a (AT1aR) in the adipose tissue of high‑fat‑fed SHRs were reversed by treatment with losartan. No difference was observed in the expression and promoter methylation of AT1R subtype b (AT1bR) among the four groups. Decreased expression and promoter hypermethylation of ATRAP were demonstrated in the adipose tissue of high‑fat‑fed SHRs. However, losartan made no difference to the expression and promoter methylation of ATRAP. Prehypertensive losartan therapy may relieve metabolic disorders in the later life of high‑fat‑fed SHRs. Differential epigenetic regulation of AT1aR and ATRAP expression through DNA methylation in adipose tissue may be involved in the long‑term beneficial effect.

View Figures

View References

1	Galassi A, Reynolds K and He J: Metabolic syndrome and risk of cardiovascular disease: A meta-analysis. Am J Med. 119:812–819. 2006. View Article : Google Scholar
2	Peng F, Lin J, Lin L and Tang H: Transient prehypertensive treatment in spontaneously hypertensive rats: A comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection. Int J Mol Med. 30:1376–1386. 2012. View Article : Google Scholar
3	Maury E and Brichard SM: Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 314:1–16. 2010. View Article : Google Scholar
4	Jing F, Mogi M and Horiuchi M: Role of renin-angiotensin-aldosterone system in adipose tissue dysfunction. Mol Cell Endocrinol. 378:23–28. 2013. View Article : Google Scholar
5	Lastra G and Sowers JR: Obesity and cardiovascular disease: Role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system. Horm Mol Biol Clin Investig. 15:49–57. 2013.
6	Bogdarina I, Welham S, King PJ, Burns SP and Clark AJ: Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circ Res. 100:520–526. 2007. View Article : Google Scholar :
7	Xiao D, Dasgupta C, Li Y, Huang X and Zhang L: Perinatal nicotine exposure increases angiotensin II receptor-mediated vascular contractility in adult offspring. PLoS One. 9:e1081612014. View Article : Google Scholar :
8	Mao C, Liu R, Bo L, Chen N, Li S, Xia S, Chen J, Li D, Zhang L and Xu Z: High-salt diets during pregnancy affected fetal and offspring renal renin-angiotensin system. J Endocrinol. 218:61–73. 2013. View Article : Google Scholar :
9	Schübeler D: Function and information content of DNA methylation. Nature. 517:321–326. 2015. View Article : Google Scholar
10	Jones PA: Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nat Rev Genet. 13:484–492. 2012. View Article : Google Scholar
11	Deaton AM and Bird A: CpG islands and the regulation of transcription. Genes Dev. 25:1010–1022. 2011. View Article : Google Scholar :
12	Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet. 355:253–259. 2000. View Article : Google Scholar
13	Maeda A, Tamura K, Wakui H, Ohsawa M, Azushima K, Uneda K, Kobayashi R, Tsurumi-Ikeya Y, Kanaoka T, Dejima T, et al: Effects of Ang II receptor blocker irbesartan on adipose tissue function in mice with metabolic disorders. Int J Med Sci. 11:646–651. 2014. View Article : Google Scholar :
14	Fernandez-Twinn DS and Ozanne SE: Early life nutrition and metabolic programming. Ann N Y Acad Sci. 1212:78–96. 2010. View Article : Google Scholar
15	Lindl T, Gross U, Ruhdel I, von Aulock S and Völkel M: Guidance on determining indispensability and balancing potential benefits of animal experiments with costs to the animals with specific consideration of EU directive 2010/63/EU. Altex. 29:219–228. 2012. View Article : Google Scholar
16	Ray MA, Johnston NA, Verhulst S, Trammell RA and Toth LA: Identification of markers for imminent death in mice used in longevity and aging research. J Am Assoc Lab Anim Sci. 49:282–288. 2010.
17	Widdop RE and Li XC: A simple versatile method for measuring tail cuff systolic blood pressure in conscious rats. Clin Sci (Lond). 93:191–194. 1997. View Article : Google Scholar
18	Xie LD, Chen DG, Zhang S, Wang HJ and Chen HJ: Sympatholytic effect of captopril in regression of cardiovascular remodeling in spontaneously hypertensive rats. Zhongguo Yao Li Xue Bao. 15:123–128. 1994.
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Method. 25:402–408. 2001. View Article : Google Scholar
20	Xie LD, Lin PS, Xie H and Xu CS: Effects of atorvastatin and losartan on monocrotaline-induced pulmonary artery remodeling in rats. Clin Exp Hypertens. 32:547–554. 2011. View Article : Google Scholar
21	Chen HF, Xie LD and Xu CS: The signal transduction pathways of heat shock protein 27 phosphorylation in vascular smooth muscle cells. Mol Cell Biochem. 333:49–56. 2010. View Article : Google Scholar
22	Wang TJ, Lin X, Lian GL, Zhong HB and Xie LD: The effect of early losartan treatment on methylation of angiotensin II type 1 receptor subtype b and angiotensin II type 1 receptor associated protein genes in the myocardium of spontaneously hypertensive rats. Chin J Hypertens. 24:141–146. 2016. View Article : Google Scholar
23	Lee AM, Gurka MJ and DeBoer MD: Trends in metabolic syndrome severity and lifestyle factors among adolescents. Pediatrics. 137:e201531772016. View Article : Google Scholar :
24	Knight SF, Quigley JE, Yuan J, Roy SS, Elmarakby A and Imig JD: Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet. Hypertension. 51:352–359. 2008. View Article : Google Scholar
25	Cao J, Inoue K, Sodhi K, Puri N, Peterson SJ, Rezzani R and Abraham NG: High-fat diet exacerbates renal dysfunction in SHR: Reversal by induction of HO-1-adiponectin axis. Obesity (Silver Spring). 20:945–953. 2012. View Article : Google Scholar
26	Tontonoz P and Spiegelman BM: Fat and beyond: The diverse biology of PPARgamma. Annu Rev Biochem. 77:289–312. 2008. View Article : Google Scholar
27	Singh KD and Karnik SS: Angiotensin receptors: Structure, function, signaling and clinical applications. J Cell Signal. 1:pii: 111. 2016.
28	Tamura K, Wakui H, Maeda A, Dejima T, Ohsawa M, Azushima K, Kanaoka T, Haku S, Uneda K, Masuda S, et al: The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/Agtrap. Curr Pharm Des. 19:3043–3048. 2013. View Article : Google Scholar
29	Shigenaga A, Tamura K, Wakui H, Masuda S, Azuma K, Tsurumi-Ikeya Y, Ozawa M, Mogi M, Matsuda M, Uchino K, et al: Effect of olmesartan on tissue expression balance between angiotensin II receptor and its inhibitory binding molecule. Hypertension. 52:672–678. 2008. View Article : Google Scholar
30	Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, Blomqvist L, Hoffstedt J, Naslund E, Britton T, et al: Dynamics of fat cell turnover in humans. Nature. 453:783–787. 2008. View Article : Google Scholar
31	Li Y, Xiao D, Yang S and Zhang L: Promoter methylation represses AT2R gene and increases brain hypoxic-ischemic injury in neonatal rats. Neurobiol Dis. 60:32–38. 2013. View Article : Google Scholar
32	McKinsey TA: Therapeutic potential for HDAC inhibitors in the heart. Annu Rev Pharmacol Toxicol. 52:303–319. 2012. View Article : Google Scholar
33	Xiao D, Dasgupta C, Chen M, Zhang K, Buchholz J, Xu Z and Zhang L: Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats. Cardiovasc Res. 101:373–382. 2014. View Article : Google Scholar
34	Cho HM, Lee HA, Kim HY, Han HS and Kim IK: Expression of Na⁺−K⁺ −2Cl⁻ cotransporter 1 is epigenetically regulated during postnatal development of hypertension. Am J Hypertens. 24:1286–1293. 2011. View Article : Google Scholar
35	Wu Z, Siuda D, Xia N, Reifenberg G, Daiber A, Münzel T, Förstermann U and Li H: Maternal treatment of spontaneously hypertensive rats with pentaerythritol tetranitrate reduces blood pressure in female offspring. Hypertension. 65:232–237. 2015. View Article : Google Scholar